Evidence map›Paper›PMID 30571465›Full record

ArticleCirculation research2018

A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse.

Maarten Hulsmans, Aaron D Aguirre, Matthew D Bonner, Aneesh Bapat, Sebastian Cremer, Yoshiko Iwamoto, Kevin R King, Filip K Swirski, David J Milan, Ralph Weissleder and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Chronic Atrial and Ventricular Pacing in the Mouse.Circulation. Heart failure · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Maarten HulsmansFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Aaron D AguirreFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Matthew D BonnerCardiac Rhythm and Heart Failure, Medtronic PLC, Mounds View, MN (M.D.B.).
Aneesh BapatCardiovascular Research Center (A.B., D.J.M., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Sebastian CremerFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Yoshiko IwamotoFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Kevin R KingFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Filip K SwirskiFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
David J MilanCardiology Division (A.D.A., D.J.M.), Massachusetts General Hospital and Harvard Medical School, Boston.
Ralph WeisslederFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Matthias NahrendorfFrom the Department of Radiology, Center for Systems Biology (M.H., A.D.A., S.C., Y.I., K.R.K., F.K.S., R.W., M.N.), Massachusetts General Hospital and Harvard Medical School, Boston.
Harvard University · USMassachusetts General Hospital · USCenter for Systems Biology · USBrigham and Women's Hospital · USMedtronic (United States) · USUniversity of California, San Diego · US

Funding

Imaging organ system interfaces in ischemic heart diseaseR35HL139598 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS · 2018 to 2024
$6.9M
Lifestyle effects on hematopoiesis and atherosclerosisR01HL128264 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS, SWIRSKI, FILIP K · 2015 to 2018
$3.3M
Quantitative nanoparticle imaging of macrophagesR01HL131495 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHRENDORF, MATTHIAS, WEISSLEDER, MD, PHD, RALPH · 2017 to 2020
$2.7M
Novel Therapy for Long QT SyndromeR01HL132905 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA · 2016 to 2019
$2.4M
Elucidating Cell Communication Networks during Tissue Inflammation, Fibrosis, and RegenerationDP2AR075321 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KING, KEVIN R · 2018 to 2018
$2.4M
Interfering with the macrophage life cycle of atherosclerosisR01HL125428 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, DANIEL G, NAHRENDORF, MATTHIAS · 2017 to 2020
$1.9M
Single Cell Imaging of the HeartR01HL122208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2014 to 2017
$1.7M
Danger Signaling and Spread of Injury after Myocardial InfarctionR00HL129168 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KING, KEVIN R · 2017 to 2019
$746k
All optical in vivo cardiac electrophysiology at cellular resolutionR21EB026762 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI AGUIRRE, AARON D · 2018 to 2020
$666k
Danger Signaling and Spread of Injury after Myocardial InfarctionK99HL129168 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KING, KEVIN R · 2015 to 2016
$309k
NHLBI NIH HHS K99 HL129168NHLBI NIH HHS R00 HL129168NHLBI NIH HHS R01 HL122208NHLBI NIH HHS R01 HL125428NHLBI NIH HHS R01 HL128264NHLBI NIH HHS R01 HL131495NHLBI NIH HHS R01 HL132905NHLBI NIH HHS R35 HL139598NIAMS NIH HHS DP2 AR075321NIBIB NIH HHS R21 EB026762
6 · The paper itself

Abstract

rationaleCardiac pacing is a critical technology for the treatment of arrhythmia and heart failure. The impact of specific pacing strategies on myocardial function is an area of intense research and high clinical significance. Mouse models have proven extremely useful for probing mechanisms of heart disease, but there is currently no reliable technology for long-term pacing in the mouse.

objectiveWe sought to develop a device for long-term pacing studies in mice. We evaluated the device for (1) treating third-degree atrioventricular block after macrophage depletion, (2) ventricular pacing-induced cardiomyopathy, and (3) high-rate atrial pacing. METHODS AND

resultsWe developed a mouse pacemaker by refashioning a 26 mm×6.7 mm clinical device powered by a miniaturized, highly efficient battery. The electrode was fitted with a single flexible lead, and custom software extended the pacing rate to up to 1200 bpm. The wirelessly programmable device was implanted in the dorsal subcutaneous space of 39 mice. The tunneled lead was passed through a left thoracotomy incision and attached to the epicardial surface of the apex (for ventricular pacing) or the left atrium (for atrial pacing). Mice tolerated the implantation and both long-term atrial and ventricular pacing over weeks. We then validated the pacemaker's suitability for the treatment of atrioventricular block after macrophage depletion in Cd11b

conclusionsLong-term pacing with a fully implantable, programmable, and battery-powered device enables previously impossible investigations of arrhythmia and heart failure in the mouse.

Indexed as

Pacemaker, ArtificialAnimalsArrhythmias, CardiacElectrodes, ImplantedEquipment DesignFemaleMaleMiceMice, Inbred C57BLMiniaturizationSoftwareTelemetryTimeartificial pacemakeratrial fibrillationatrioventricular blockcardiac arrhythmiaheart failureinflammationmice

Identifiers

PMID30571465
PMCPMC6309285
OpenAlexW2897605084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.